More Than 50 New Medicines for HIV treatment to be Developed

17 July 2017 09:36

More  than 50 new drugs for HIV treatment are developed all over the World, said the Medicines in Development report by The Pharmaceutical Research and Manufacturers of America (PhRMA).

The majority of people living with HIV take not only one drug, but use combination of two or three drugs in one pill. Using one pill is easier - patient have few chances to forget about his drug intake and a few chances to improve his health and to increase the drug adherence.

Now there are about 45 drugs for HIv treatment and care approved in the USA, more than 50 new medicines are being developed. New medicines will be useful not only for HIV-positive patients, but also for broader public health, biopharmaceutical industry and health care community.

“Thanks to the hard work and dedication of countless individuals – from biopharmaceutical researchers, to those patients enrolled in clinical trials – we have seen an 88 percent decline in the HIV/AIDS death rate since the 1990s, and an estimated 862,000 premature HIV/AIDS deaths have been prevented in the United States. While we have made great progress, there is more to be done, which is why the 52 medicines and vaccines in development offer tremendous hope and inspiration that an AIDS-free generation may one day be in reach.” - said Stephen J. Ubl, president and chief executive officer of PhRMA.


Share with Telegram

Latest News

New high-quality pill for HIV to be launched in low-and middle-income countries at reduced price

New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low-and middle-income countries at reduced price. For about $75, the governments in South Africa and Kenya will soon be able to treat an HIV-infected person for 1 year with a pill taken ...

22 September 14:27

Marathon training is safe for people with HIV

Marathon run training is safe for people with HIV, investigators from Germany report. Training also had a number of beneficial effects, including a significant increase in CD4 cell count and improvements in cholesterol and blood pressure. «The main finding of our study was ...

21 September 13:44

Sanofi tests three-in-one antibody to treat or prevent HIV

A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV, following successful tests in monkeys. If all goes well, the three-in-one antibody could be used either as a long-acting treatment or ...

21 September 12:28

By 2020, 70% of people living with HIV in the US will be 50 or older

Due to enormous advances in treatment, people are able to live far longer; so much so that by the year 2020, 70 percent of those living with HIV in the US will be over the age of 50. This is good news, but it brings with it unique complexities. Philanthropic funding is a ...

20 September 14:53